Ribbon Acquisition Corp. Reports Q3 2025 Financial Results with Net Income of $62,142

Ribbon Acquisition Corp. has reported its financial results for the third quarter of 2025, revealing a net income of $62,142 for the three months ending September 30, 2025, compared to a net loss of $10,305 for the same period in the previous year. For the nine months ended September 30, 2025, the company recorded a net income of $569,295, a significant increase from the prior year's loss of $10,305. The company’s total operating expenses for the quarter were $463,712, while for the nine-month period, they totaled $892,007. The income earned on marketable securities held in the Trust Account contributed positively, amounting to $525,854 for the quarter and $1,461,302 for the nine months.

The financial position of Ribbon Acquisition Corp. has changed markedly since the end of 2024. As of September 30, 2025, total assets stood at $51,580,219, a substantial increase from $508,662 at the end of the previous fiscal year. This growth is primarily attributed to the successful completion of the Initial Public Offering (IPO) on January 16, 2025, which raised $50 million from the sale of 5,000,000 units at $10.00 each. The company also completed a private placement of 220,000 units, generating an additional $2.2 million. The cash and marketable securities held in the Trust Account reached $51,461,310, reflecting the funds raised during the IPO.

Operationally, Ribbon Acquisition Corp. has not yet commenced any business activities, as it is a blank check company focused on identifying a target for a business combination. The company has until January 16, 2026, to complete its initial business combination, or it will face automatic liquidation. As of the reporting date, the company had a working capital deficit of $190,092 and net cash used in operating activities of $637,983. The company has incurred significant costs related to its IPO and anticipates ongoing expenses as it seeks a suitable business combination.

In terms of strategic developments, Ribbon Acquisition Corp. entered into a Business Combination Agreement on June 30, 2025, with DRC Medicine Inc., which specializes in AI-powered allergy and infection diagnostic kits. This agreement outlines a share exchange and a merger that will transition Ribbon from a Cayman Islands entity to a Delaware corporation. The completion of this merger is contingent upon various conditions, including shareholder approvals and regulatory compliance. The company is actively preparing to file a registration statement with the SEC to facilitate this transaction.

Looking ahead, Ribbon Acquisition Corp. remains focused on executing its business strategy, although management has expressed concerns regarding its ability to continue as a going concern if a business combination is not completed within the specified timeframe. The company has indicated that it will continue to seek opportunities for growth and expansion, leveraging the funds raised through its IPO and private placement to finance its operations and potential acquisitions.